Showing results (2401-2410 of 2,473) with videos related to

Sort By:
Pageof 248
Cancer Treatment Reviews|December 14, 2025
Primary tumor and metastasis-directed treatment for oligometastatic prostate cancer: An umbrella review of meta-analysesFausto Petrelli, Francesca Trevisan, Lorenza Bruschieri, et al.
Cancer Treatment Reviews|June 21, 2025
PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)]L Cortesi, F Miglietta, L Arecco, et al.
Cancer Treatment Reviews|February 22, 2025
Comparative efficacy and safety of pyrotinib plus trastuzumab versus trastuzumab plus pertuzumab and trastuzumab monotherapy in neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysisYe Yuan, Xumei Liu, Gaifeng Xu, et al.
Cancer Treatment Reviews|February 26, 2025
BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectivesStefania Napolitano, Davide Ciardiello, Eleonora Cioli, et al.
Cancer Treatment Reviews|March 14, 2025
First-line treatment of locally advanced cervical carcinoma: An updated systematic review and Bayesian network meta-analysisFausto Petrelli, Valentina Riboldi, Lorenza Bruschieri, et al.
Cancer Treatment Reviews|February 25, 2025
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physiciansEnrique Grande, Syed A Hussain, Philippe Barthélémy, et al.
Cancer Treatment Reviews|February 20, 2025
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the targetGiannis Mountzios, Stephanie P L Saw, Lizza Hendriks, et al.
Cancer Treatment Reviews|January 12, 2025
Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinomaMatteo Santoni, Veronica Mollica, Alessandro Rizzo, et al.
Cancer Treatment Reviews|March 8, 2025
Identification of the PROMs used to assess ICI toxicities and HRQoL in patients receiving immune checkpoint inhibitor treatment in cancer care and their suitability: A systematic reviewSofia Georgopoulou, Joanne Droney, Poorni Priya Jaganathan, et al.
Cancer Treatment Reviews|March 7, 2025
First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?Flora Nguyen Van Long, Brigitte Poirier, Christine Desbiens, et al.
Pageof 248